Navigation Links
Genoptix Announces Participation at the Barclays Capital 2010 Global Healthcare Conference
Date:3/15/2010

CARLSBAD, Calif., March 15 /PRNewswire-FirstCall/ -- Genoptix, Inc. ( GXDX), a specialized laboratory services provider, today announced the Company's participation at the Barclays Capital 2010 Global Healthcare Conference at the Loews Miami Hotel in Miami, Fla. to be held March 23-24, 2010.  

Doug Schuling, EVP and CFO of Genoptix, will present at the conference on Tuesday, March 23, 2010 beginning at approximately 2:30 p.m. EDT, when he will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 25 minutes and will be web cast live through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix is a member of the Nasdaq Select Global Market and the S&P SmallCap 600 Index and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.

SOURCE Genoptix, Inc.

Back to top

RELATED LINKS
http://www.genoptix.com

'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009
2. Genoptix, Inc. to Announce Second Quarter 2009 Financial Results
3. Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
4. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
5. Genoptix Reports Strong Growth for the First Quarter of 2009
6. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
7. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
8. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
9. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
10. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
11. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
Breaking Medicine Technology: